Intressanta studier med Mylotarg (gemtuzumab ozogamizin)
Effect of gemtuzumab ozogamicin on survival of adult patients with de-novo acute myeloid leukaemia (ALFA-0701): a randomised, open-label, phase 3 study
Castaigne et al, Lancet, 2012 Apr 21;379(9825):1508-16
https://pubmed.ncbi.nlm.nih.gov/22482940/
Gemtuzumab ozogamicin for de novo acute myeloid leukemia: final efficacy and safety updates from the open-label, phase III ALFA-0701 trial
Lambert et al, Haematologica, 2019 Jan;104(1):113-119
https://pubmed.ncbi.nlm.nih.gov/30076173/
PP-MYL-SWE-0060, mar 2022